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Abstract
Objectives: Sickle cardiomyopathy is the most important cause of death in patients with sickle cell disease (SCD). Based
on recent evidence, SCD can be divided into two subphenotypes, namely, the viscosity vaso-occlusion (VVO) subphenotype and the hemolysis endothelial dysfunction (HED) subphenotype. The aim of our series is to study right
ventricular (RV) functions in both subphenotypes.
Methods: Echocardiography including conventional and tissue Doppler imaging as well as speckle tracking echocardiography was performed in 50 patients (23 from the VVO subgroup and 27 from the HED subgroup) based on a serum
lactate dehydrogenase (LDH) level below or above 270 U/L, respectively, and in 50 controls. Reticulocyte count and
hemoglobin levels were assessed in different groups of patients.
Results: The HED subgroup showed RV dysfunction. Patients in this subgroup also showed systolic and diastolic
functions similar to those seen in the VVO subgroup and controls. In addition, a tight correlation exists between LDH
and both RV global longitudinal strain (e0.68) and RV E/E′ ratio (0.9), deﬁned as the ratio of early diastolic tricuspid
inﬂow velocity to tricuspid annular early diastolic velocity.
Conclusions: Results reveal a marked discrepancy in RV functions between HED and VVO subphenotypes of SCD,
with patients in the former subgroup being more prone to RV dysfunction. This warrants early screening of such patients in daily practice.
Keywords: Hemolysis endothelial dysfunction, Lactate dehydrogenase, Right ventricular functions, Viscosity vaso-occlusion

1. Introduction

C

ardiopulmonary complications are the
leading cause of mortality in patients with
sickle cell disease (SCD) [1].
In recent years, two distinct phenotypes have been
identiﬁed in SCD: the viscosity-vaso-occlusion subphenotype [viscosity vaso-occlusion (VVO)], in which
patients suffer mainly from severe vaso-occlusive
crises with mildly elevated or non-elevated lactate

dehydrogenase (LDH) levels, and the hemolysis
endothelial dysfunction (HED) subphenotype, in
which patients suffer mainly from stroke and pulmonary hypertension with markedly elevated LDH
levels as a result of high rates of intravascular hemolysis depleting nitrous oxide levels, thus inducing
microvascular dysfunction [2]. To our knowledge,
few have studied the discrepancy in myocardial
dysfunction, especially of the right ventricle (RV),
between the VVO and HED subphenotypes. Besides
being outdated, available studies only weighed the
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discrepancy of pulmonary hypertension and death
risk rather than performing a true assessment of
myocardial dysfunction across different phenotypes
[3,4]. In addition, a wide disagreement exists about
the state of systolic myocardial dysfunction in cases
with SCD. Most series [5e7] claim that left ventricular
strains are normal and comparable to matched controls in cases with SCD while fewer studies contradict
such a ﬁnding and conﬁrm the presence of subtle
systolic dysfunction especially during vaso-occlusive
crises [8]. Such contradictions may raise the need to
re-examine systolic function of the myocardium
across divergent phenotypes, in order to identify the
existence of a potential difference that might be
responsible for the varying ﬁndings reported in this
regard.
The aim of this study is to review the RV systolic
and diastolic functions in the two subphenotypes of
SCD to be able to conﬁrm or preclude if a certain
subphenotype needs a more close follow-up of its
myocardial functions than the other.

2. Patients and methods

I. YOUSSRY ET AL

35

Abbreviations
BSA
Cm
dL
E
E0
ECG
GE
Kg
LDH
m2
MHz
mL
Mm
Msec
Ng
NO
PAP
SD
SCD
SPSS
TDI
TRV
2-D
U
USA

Body surface area
Centimeter
Deciliter
Early diastolic inﬂow velocity
Early diastolic tissue velocity
Electrocardiogram
General Electric
Kilogram
Lactate dehydrogenase
Square meter
Mega Hertz
Milliliter
Millimeter
Millisecond
Nanogram
Nitrous oxide
Pulmonary artery Pressure
Standard deviation
Sickle cell disease
Statistical package for social science
Tissue Doppler imaging
Tricuspid regurgitant velocity
Two dimensional
Unit
United State of America

2.1. Study population
This was a cross-sectional study conducted between June 2017 and July 2018, and included two
groups: Group 1 and Group 2.

guardians and obtaining the approval of the ethical
committee of Cairo University, Cairo, Egypt.
2.2. Methods

2.1.1. Group 1
The group included 50 children of both sexes with
SCD. Children were between 6 and 9 years of age
(mean: 7.28 ± 1.48 years). A total of 25 patients were
females (50%) and 25 were males (50%), with positive consanguinity in 30/50 (60%) patients. The frequency of blood transfusion per year ranged
between
one
and
24 times/yr
(mean:
5.57 ± 4.99 times/yr). Patients with symptoms or
signs suggesting pulmonary or cardiac abnormalities were excluded from the study. The group was
subdivided into two based on subphenotype: Group
1A, including patients with the VVO subphenotype
(n ¼ 23); and Group 1B, including patients with the
HED subphenotype. The discrimination was performed based on an LDH cutoff of 270. Patients with
an LDH level <270 U/L were included in the VVO
subphenotype and those with an LDH level 270 U/
L were included in the HED subphenotype [9].
2.1.2. Group 2
Fifty healthy children matched for age, sex, and
body surface area were set as the control group.
Both groups were enrolled in the study after
obtaining consent from the patients or their legal

Patients were subjected to full clinical assessment
and clinical deﬁnitions, echocardiography, and laboratory investigations.
2.2.1. Clinical assessment and clinical deﬁnitions
All included patients were subjected to (1) full history taking and (2) clinical examination (complete
general and systemic examination) with special
attention to anthropometric measurements including
body weight (kg), height (cm), and heart rate. Data
were collected on SCD complications in the two
deﬁned subgroups following the methodology recommended by Van Der Land et al. [10]. Vaso-occlusive pain episodes were expressed as number of
episodes per patient per year (in the past 3 years).
Stroke was deﬁned as a focal neurological deﬁcit at the
time of the study with evidence on neuroimaging of a
cerebral infarct corresponding to the focal deﬁcit
(expressed as number of patients with evidence on
neuroimaging per affected patients) at the time of the
study. Acute chest syndrome was deﬁned as a new
inﬁltrate on chest radiograph in the presence of pulmonary symptoms and expressed as number of patients having more than one episode per year. Leg
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ulcers were deﬁned as painful skin defects on lower
legs and expressed as number of affected patients at
the time of examination.
2.2.2. Echocardiography
Echocardiography was performed according to
the protocol recommended by DiLorenzo et al. [11]
for assessment of RV functions (but with some
modiﬁcations for the purpose of this study rather
than for routine assessment). The procedure was
performed using a GE ultrasound system (GE Vivid
7 Dimension; GE Healthcare, Horten, Norway) with
probe frequencies appropriate for patient size according to the guidelines for performing echocardiogram published by the American Society of
Echocardiography [12]. The motion-mode (Mmode) was used to calculate tricuspid annular plane
systolic excursion.
2.2.2.1. Continuous wave Doppler. This is one of the
ﬁrst tools used to estimate the presence of pulmonary hypertension in any group, which involves
measuring the pulmonary artery pressure. In this
study, the tricuspid gradient was estimated from
peak tricuspid regurgitation velocity (TRV), with
TRV >2.5 m/s considered signiﬁcant for pulmonary
hypertension [13].
2.2.2.2. Conventional and tissue Doppler method. RV
diastolic function was assessed using the RV E/E0
ratio, which is deﬁned as the ratio of early diastolic
tricuspid inﬂow velocity to the early diastolic tricuspid
annular velocity. An E/E0 ratio >15 was considered
suggestive of RV diastolic dysfunction [14].
2.2.2.3. 2D speckle tracking echocardiography. Digital
loop ECG recording was obtained for the RV in

four-chamber view and analyzed by the EchoPAC
(General Electric, Horten, Norway) ofﬂine analysis
software for calculation of global longitudinal strain
of RV using the average of the three segments of RV
free wall.
Echocardiography was performed by two senior
cardiologists who were blinded for the phenotype of
SCD, including laboratory data, and subsequent
kappa analysis for intra- and interobserver variability was performed.
2.2.2.4.
Laboratory
investigations. Hemoglobin,
platelet, and LDH levels were measured after
collection of samples in dry tubes. Serum LDH
assays were performed with a spectrophotometer
at 340 nm. The LDH assay kit was provided by
Cypress Diagnostics (Hulshout, Belgium) [15]
with a reference range between 160 and 320 U/L.
Reticulocyte counts and fetal hemoglobin (percentage) were measured in the studied cases
only.
2.3. Statistical analysis
Data were statistically described in terms of
mean ± standard deviation. A comparison of numerical variables between the study groups was
performed using a paired t-test (normal distribution). For comparisons of multiple groups, the
TurkeyeKramer test was applied, with individual p
values listed in Table 1. Correlation between
various variables was done using the Pearson
moment correlation equation. All p values <0.05
were considered statistically signiﬁcant. All statistical calculations were done using SPSS for
Microsoft Windows (version 15; SPSS Inc., Chicago, IL, USA).

Table 1. Demographic and clinical criteria of the three study groups.
Variables

Group 1A (n ¼ 30) Group 1B (n ¼ 30) Control, Group 2 (n ¼ 25) p valuea,* p valueb,* p valuec,*

Age (yr)
12 ± 3
HR (BPM)
86 ± 8
BSA (m2)
1.2 ± 0.02
Frequency of blood transfusion (mL/kg/yr) 152 ± 15
Hb (g/dL)
10 ± 3.1
Platelets (109/L)
301 ± 120
Reticulocyte count
4
Serum LDH (U/L)
457 ± 51

12 ± 4
85 ± 5
1.3 ± 0.01
240 ± 22
8.5 ± 1.9
421 ± 77
8
125 ± 10

12 ± 3
84 ± 10.4
1.2 ± 0.02
e
e

NS
NS
NS
e
e

NS
NS
NS
e
e

NS
NS
NS
<0.01
<0.01
<0.01

e

e

e

<0.01

Data are presented as mean ± standard deviation or %.
BPM ¼ beats per minute; BSA ¼ body surface area; HR ¼ heart rate; LDH ¼ lactate dehydrogenase; SD ¼ standard deviation; NS ¼ nonsigniﬁcant.
a
Between Groups 1A and 2.
b
Between Groups 1B and 2.
c
Between Groups 1A and 1B.
*
A p value <0.05 was considered statistically signiﬁcant.
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3. Results

4. Discussion

Clinical characteristics of the studied population
(Groups 1A and 1B) were matched for age, heart
rate, and body surface area, and compared with
controls (Group 2; Table 1). Group 1B showed
higher hemolysis indices as conﬁrmed by the
greater need for blood transfusion, higher LDH, and
lower hemoglobin.
Table 2 summarizes the discrepancy of clinical
manifestations between the two subphenotypes of
SCD. Data show that vaso-occlusion is higher in the
VVO subgroup, whereas more leg ulcers and higher
evidence of cerebral infarcts were noted in the HED
subgroup.
As can be seen in Table 3, parameters suggesting RV dysfunction are obvious in Group 1B.
However, the RV functions showed no statistically
signiﬁcant difference between Group 1A and
controls (Group 2).
Figs. 1 and 2 present two regression curves
demonstrating tight correlation between RV global
longitudinal strain and RV E/E0 ratio on the one
hand and LDH on the other.
The intraobserver variability was low for each
cardiologist; for Cardiologist 1 kappa coefﬁcient was
0.91, whereas for Cardiologist 2 it was 0.89. The
interobserver variability was also very trivial with a
kappa coefﬁcient of 0.87.

Sickle cell is more than just a hemolytic anemia.
Some patients with sickle cell anemia do not present
with hemolysis or anemia. Instead, these patients
may initially encounter severe pain from vaso-occlusion or right-sided heart failure as a result of
myocardial involvement [10].
The wide spectrum of manifestations seen in SCD
and the weight exerted by SCD cardiomyopathy on
mortality and morbidity make it mandatory to
detect SCD cardiomyopathy early and to elucidate
the risk factors and at-risk groups to stratify the
patients according to the presence or absence of
such risks.
As mentioned earlier, SCD can be subdivided into
two main subphenotypes: VVO and HED. These
two phenotypes differ in their severity of manifestations, but few series have underlined the
discrepancy in cardiac dysfunction across these
subphenotypes [9].
In this series, we compared hematologic clinical
data and laboratory data as well as RV myocardial
functions between the two subphenotypes. The
major study ﬁndings were the lower rate of hemoglobin, the higher need for blood transfusion, and
the higher LDH levels (initial discriminating factor)
in the HED phenotype, which were all expected in
this subgroup [2].

Table 2. Clinical manifestations among the subgroups of the disease.
Variables

Group 1A (n ¼ 30)

Group 1B (n ¼ 30)

p valuea,*

Vaso-occlusive events (number of events per patient/yr)
Cerebral infarcts (affected patients/patients with available imaging)
Acute chest syndrome (number of patients with 1 episode)
Leg ulcers (affected patients)

2.4
0/0
6
2

1.1
1/2
2
7

0.04
0.04
<0.01
<0.01

a
*

Between Groups 1A and 1B.
A p value <0.05 was considered statistically signiﬁcant.

Table 3. Echocardiographic parameters of systolic and diastolic function of RV in the three study groups.
Variables

Group 1A (n ¼ 30)

Group 1B (n ¼ 30)

Controls Group 2 (n ¼ 25)

p valuea,*

p valueb,*

p valuec,*

TAPSE (mm)
TR velocity (m/s)
RV E/E0 ratio
RV GLS (%)

22 ± 2
1.4 ± 0.42
6.5 ± 1.4
e22 ± 2

21 ± 3
1.5 ± 0.41
14 ± 2
15 ± 1.2

20 ± 2
1.4 ± 0.32
6.2 ± 1.1
21 ± 3

NS
NS
NS
NS

NS
NS
<0.01
<0.01

NS
NS
<0.01
<0.01

Data are presented as mean ± standard deviation.
GLS ¼ global longitudinal strain; RV ¼ right ventricle; RV E/E0 ¼ ratio of early diastolic tricuspid inﬂow velocity to the early diastolic
tricuspid annular velocity; TAPSE ¼ tricuspid annular plane systolic excursion; TR ¼ tricuspid regurgitant velocity; SD ¼ standard deviation; NS ¼ Non signiﬁcant.
a
Between Groups 1A and 2.
b
Between Groups 1B and 2.
c
Between Groups 1A and 1B.
*
A p value <0.05 was considered statistically signiﬁcant.
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Fig. 1. Correlation of LDH with RV E/E0 ratio. LDH ¼ lactate dehydrogenase serum level; R2 ¼ correlation coefﬁcient of regression analysis; RV ¼ right ventricle; RV E/E0 ¼ ratio of early diastolic tricuspid
inﬂow velocity to early diastolic tricuspid annular velocity.

Fig. 2. Correlation of LDH with RV GLS. LDH ¼ lactate dehydrogenase
serum level; R2 ¼ correlation coefﬁcient of regression analysis;
RV ¼ right ventricle; RV GLS ¼ right ventricular global longitudinal
strain.

Besides, the other ﬁndings that conﬁrm the role of
LDH as a discriminating factor between these two
clinical subphenotypes are the higher rate of vasoocclusion and its surrogate manifestations such as
the acute chest syndrome in the VVO subgroup and
the presence of ischemic manifestations such as
cerebral infarcts and skin ulcers in the HED subgroup. This result agrees with those reviewed by
Habara et al. [2] regarding the frequency of manifestations in each group.
A relatively striking ﬁnding in this study is the
lack of a statistically signiﬁcant elevation in pulmonary artery pressure in both groups of patients
compared with controls. This ﬁnding, however,
disagrees with the review by Habara et al. [2], who
noted that the HED group is susceptible to pulmonary hypertension. Based on recent evidence as
well as reports of over-diagnosis of pulmonary
hypertension in patients with SCD, Mushemi-Blake
et al. reported that pulmonary hypertension in SCD
is rather a state of overﬂow due to hyperdynamic
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circulation and that pulmonary hypertension is
unrelated to RV dysfunction in this patient group
[17,17].
Several studies, such as those by Barbosa et al. and
Ahmad et al. [6,7], have concluded that ventricular
strains are not reduced but might be increased in cases
with SCD. A recent study by AbdelMassih et al. [18]
showed that left ventricular strains are reduced in
patients with SCD mainly in the subendocardium
with overall preserved left ventricular global longitudinal strain. AbdelMassih et al. [18] compared the
pattern of left ventricular dysfunction in thalassemia
with SCD and proved that the patients with SCD
experience early subendocardial involvement. The
latter ﬁnding raises the suspicion of possible lack of
vascular relaxibility in SCD as an underlying pathogenesis for the observed dysfunction. However, none
of the studies has compared the ventricular strains in
different phenotypes. Our study shows a normal
strain in the VVO group; by contrast, the HED group
has a markedly reduced RV strain compared with
controls. This contradicts the ﬁxed clich
e about nonreduced strains in patients with SCD and underlines
the neglected discrepancy between different phenotypes. This might also explain the observed ventricular dysfunction in the study by AbdelMassih et al. [18],
whereby the HED phenotypes develop vascular stiffness due to intravascular hemolysis that can impair
the subendocardial function of both ventricles.
Moreover, RV dysfunction was marked in the HED
group and no data are available that can be compared
with our series. The observed difference between the
two phenotypes and the tight correlation between
measures of RV function and LDH might be explained
by the fact that microvascular dysfunction characteristic of the HED group may induce subendocardial
ischemia, with the latter inducing impaired functions
in patients with SCD. This is in agreement with Sengupta et al. [8] who reported reduced subendocardial
strain in patients with SCD.

5. Conclusion
SCD subphenotypes do not show uniform manifestations across different subphenotypes. The HED
subphenotype clearly displays more ventricular
dysfunction compared with the VVO group. Thus,
LDH can be used as a stratifying factor to screen
patients for RV dysfunction.
5.1. Limitations and future projects
Larger sample sizes are needed to generalize the
results of this study. Because of ﬁnancial reasons, a
correlation analysis between genetic variabilities in

SCD and the observed RV dysfunction, and exploration of the relationship between SCD subphenotypes and SCD-causing mutations could not
be performed.
In addition, the latter ﬁndings should serve as a
basis for further research to underline the pathogenesis of ventricular dysfunction in the HED
group. We aim in our next study to compare LV
functions across the two subphenotypes.
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Quote by Antoine Fakhry abdelMassih (the 3rd author): Each formerly discovered illness seemed at a time a single entity. There is an
increasing body of evidence that points to the fact that each disease has multiple variable copies. Every person might end up with a
different version of the same disease. The increasing understanding of such hypothesis is part of an enlarging branch in medicine, which
is “personalized medicine.” We no longer should treat a disease but we should rather treat “the patient with that disease.” We seem to
have been born not only with a predeﬁned copy of our characters and shape but also our fate.
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